Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.
about
Discovery and Current Status of Evaluation System of Bioavailability and Related Pharmaceutical Technologies for Traditional Chinese Medicines--Flos Lonicerae Japonicae--Fructus Forsythiae Herb Couples as an ExampleOral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsIn silico, experimental, mechanistic model for extended-release felodipine disposition exhibiting complex absorption and a highly variable food interactionClarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique.Valproic acid-hydrophilic cyclodextrin complexes and valproic acid-solid dispersions: evaluation of their potential pharmaceutical use.Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques.CLSM as quantitative method to determine the size of drug crystals in a solid dispersion.Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems.Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals.Enhanced dissolution rate of felodipine using spherical agglomeration with Inutec SP1 by quasi emulsion solvent diffusion method.Drug product development: a technical review of chemistry, manufacturing, and controls information for the support of pharmaceutical compound licensing activities.Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the AmericasPhysical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer.Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology.Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note.Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugsBiomagnetic methods: technologies applied to pharmaceutical research.Ionic liquids as active pharmaceutical ingredients.Excipients with specialized functions for effective drug delivery.The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs.Pros and cons of methods used for the prediction of oral drug absorption.Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.A proposed food breakdown classification system to predict food behavior during gastric digestion.Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay.Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier.Generic immunosuppressants.Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology.Evaluation of the DDSolver software applicationsComparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.
P2860
Q26824285-95C0C250-4732-44F8-8D99-08295CF5C9CCQ28534686-70BE4E19-B709-4750-B07F-9F07B364FD0DQ28543408-CB05DE8F-CD00-49D8-9517-6847A611463FQ30430057-A066C284-CD42-4726-A848-424A18820DABQ30909831-455B6FDA-8A23-498C-901B-4CAD74B4C95DQ33526818-826A8DA6-EDA4-45E3-AD38-70310673B565Q33910031-4A983EE6-43FF-492B-B199-F1444AEB5907Q34273688-B21EAB9D-CF18-45BA-A613-B118F3AC2F7DQ34285667-7F7881CA-2F2D-4CAF-A4E4-F2E7953AC153Q34409932-EC0C20C3-7982-4654-B42C-BCA840464164Q34665881-35164A36-BCF0-4D94-8290-CC78A3E9EBAAQ34978286-B47FB921-6BDD-4EF3-98BD-18178B2CA003Q35579328-B7B0F88C-0E96-461D-848A-E83AD2443719Q35756163-BB00993E-B65B-48D1-BAA7-174D03ED5C6EQ35851242-4F9490D6-72C8-49A0-B3D9-668110278BC6Q36065582-DB37F310-33E2-4C20-ADE8-2F6589E94112Q36185904-3D79B771-4F76-4D88-821A-3EFAECC420FCQ36909311-7FE78B67-0EED-420C-AEEF-2315D247B251Q36975416-2C5255B4-83BF-4098-BDF5-D946E00C9F42Q37058658-5BEB5D3F-D9AC-4E26-AADC-176775769D85Q37360630-FCB2AA37-3341-4586-9E2A-B2B0B9769B56Q37360897-907D30A4-8E6F-44EA-B3F7-FE98F03489DAQ37624491-C2B86E67-F56A-4265-851D-2C7A07388B4CQ37800414-858634EC-35AB-4A4D-AA59-2FFF12567687Q37873895-CF1AC9C8-DECE-46B2-A559-4F2913C75F0EQ37971124-12241888-D41B-4562-BFB4-3DA1185DD7A4Q37990748-04B4B395-2F5B-4F8E-8309-4DE7C50AD65BQ38150850-393C1080-5E29-4BA5-B5F5-A11014F872AEQ38177366-A04CB367-19FF-439B-A1F3-5C588AC77571Q38183877-C6265355-1D6E-4715-8099-2090884064F3Q38848809-BACA49D0-6955-4973-AE3F-3904289CA862Q38922030-CE1C9E04-82AA-43FF-82AB-0E586443FD5AQ39021086-68B39254-DFB7-4B4D-AFC2-D19E384E1FD5Q39203327-1AF9688F-B5B6-41EF-9453-6873C78AD4EAQ39424063-0D8E065D-6848-4F07-8A9A-1287AFBFD535Q39451470-FDFEFBD0-3571-4DDA-B47C-A85E84D62848Q39571388-C7283243-2340-45DD-8920-90C087AB5B57Q39646408-3CA44E0F-AEF3-4FA7-9D99-9DADDA701ABCQ39753341-C58B2B3E-A002-4364-A656-CCA2F7761B14Q40335951-254AFE3D-277B-40CF-96FE-3A408FD94C1B
P2860
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Modern bioavailability, bioequ ...... national regulatory standards.
@ast
Modern bioavailability, bioequ ...... national regulatory standards.
@en
type
label
Modern bioavailability, bioequ ...... national regulatory standards.
@ast
Modern bioavailability, bioequ ...... national regulatory standards.
@en
prefLabel
Modern bioavailability, bioequ ...... national regulatory standards.
@ast
Modern bioavailability, bioequ ...... national regulatory standards.
@en
P1476
Modern bioavailability, bioequ ...... national regulatory standards.
@en
P2093
Löbenberg R
P356
10.1016/S0939-6411(00)00091-6
P407
P577
2000-07-01T00:00:00Z